Spread of Extensively Drug-resistant Tuberculosis

نویسندگان

  • Sofía Samper
  • Carlos Martín
چکیده

To the Editor: An emergency has been declared in KwaZulu Natal, South Africa, where an outbreak of 53 cases of a highly lethal form of tuberculosis (TB) has occurred (1,2). This outbreak was caused by an extensively drug-resistant TB (XDR TB) strain. XDR TB is defined as TB caused by Mycobacterium tuberculosis isolates resistant to isoniazid and rifampicin plus any fluoroquinolone and >1 of the 3 injectable second-line drugs (3). XDR TB may be considered an emerging disease but not a new disease. Nosocomial outbreaks of multidrug-resistant TB (MDR TB) occurred in Spain at the height of the HIV epidemic, when 49 TB cases were reported in an HIV ward in Madrid from 1991 through 1995 (4,5). Molecular epidemiology found that a particular strain caused 16 cases In total, 22 hospitals from 6 different regions of Spain were affected by this outbreak, which included at least 114 cases, caused by an M. bovis XDR strain (B strain) belonging to the M. tuberculosis complex. The patients included 1 from the Netherlands (8) and another from Canada (9). The strain responsible for the 1991–1995 outbreak in Spain fits the XDR TB case definition; it was resistant to the 5 first-line drugs, as well as to ofloxacin, aminosalicylic acid, cycloserine, ethionamide, capre-omycin, amikacin, and clar-ithromycin. Isolates were tested for drug susceptibility by the Canetti method on Lowenstein-Jensen medium supplemented with isoniazid, rifampicin, ethambutol, streptomycin, amikacin, and pyrazinamide (6). The isolates were also tested on 7H10 Middlebrook agar for susceptibility to aminosalicylic acid, ethionamide, capreomycin, clarithromycin, and ofloxacin (6). No effective medical treatment was available for these patients. In 2 of the hospitals affected, all patients died, with a short survival time (median of 44 and 49.5 days for the 2 hospitals) between diagnosis and death (6,7). A high rate of reinfec-tion (45%) also was noted among HIV-positive patients treated with anti-TB drugs (7). As a result of this outbreak, Spanish hospitals now implement exhaustive control measures , such as maintaining respiratory isolation units under negative pressure ; in addition, a national surveillance network for MDR TB was set up in Spain in 1998. From 1998 through 2003, we detected 22 new cases of infection with this strain (10), but no new cases have since been reported to the national MDR TB database. Our experience indicates that the implementation of more stringent control measures and the use of new, more effective treatments for HIV …

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Multidrug-resistant and extensively drug-resistant tuberculosis: a review of current concepts and future challenges.

Multidrug-resistant and extensively drug-resistant tuberculosis are recent global health issues, which makes tuberculosis - after the success of short course treatment during the second half of the last century - a major health challenge. Globalisation, health inequalities, competing economic interests and political instability contribute substantially to the spread of drug-resistant strains, w...

متن کامل

Nanomedicine for tuberculosis: Insights from animal models

Patient noncompliance to current tuberculosis (TB) therapy owing to multidrug administration daily leads to treatment failure and emergence of multidrug resistant and extensively drug resistant TB. To avoid the daily dosing, application of nanotechnology is the only viable solution by virtue of sustained release of drugs. Other potential advantages of the system include the possibility of selec...

متن کامل

Drug-resistant TB: deadly, costly and in need of a vaccine

TB is an underappreciated public health threat in developed nations. In 2014, an estimated 9.6 million TB cases and 1.5 million deaths occurred worldwide; 3.3% of these cases resulted from multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) strains. These figures underestimate the economic burden associated with MDR-TB and XDR-TB, as the cost of treati...

متن کامل

Nanomedicine for tuberculosis: Insights from animal models

Patient noncompliance to current tuberculosis (TB) therapy owing to multidrug administration daily leads to treatment failure and emergence of multidrug resistant and extensively drug resistant TB. To avoid the daily dosing, application of nanotechnology is the only viable solution by virtue of sustained release of drugs. Other potential advantages of the system include the possibility of selec...

متن کامل

Multidrug-Resistant Tuberculosis and Extensively Drug-Resistant Tuberculosis.

The continuing spread of drug-resistant tuberculosis (TB) is one of the most urgent and difficult challenges facing global TB control. Patients who are infected with strains resistant to isoniazid and rifampicin, called multidrug-resistant (MDR) TB, are practically incurable by standard first-line treatment. In 2012, there were approximately 450,000 new cases and 170,000 deaths because of MDR-T...

متن کامل

Pulmonary Tuberculosis Disseminating and Presenting as Bilateral Hydronephrosis and Renal Abscess: a Potential Threat in the Era of Multi-Drug Resistant Tuberculosis MDR-TB

Mycobacterium tuberculosis, the causative agent of tuberculosis was discovered by Robert Koch in 1882. It has been observed that 30% of the world population harbours Mycobacterium tuberculosis. Spread of Human immunodeficiency virus (HIV) infection, malignancies, globalization and malnutrition are some of the major contributing factors for increase in the global burden of tuberculosis (pulmonar...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره 13  شماره 

صفحات  -

تاریخ انتشار 2007